Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BM-35
- Development stage
- Unknown
- Lead developer
- BM Homoeopathic Pharmaceuticals
- Administration
- Oral
01
Overview
**BM-35** is a multi-ingredient homeopathic oral-drop product from BM Homoeopathic Pharmaceuticals for symptomatic use in lumbago and sciatica, including back pain radiating along the sciatic nerve. The stated formulation includes homeopathic preparations of belladonna, bryonia alba, calc phos, colchicum, colocynthis, dioscorea, and rhus tox. It has no established conventional pharmacologic target or evidence-based molecular mechanism of action. Retail listings identify it as a 30 mL homeopathic medicine manufactured by BM Homoeopathic Pharmacy. ([homeostore.pk](https://homeostore.pk/product/bm35/))
- Other names
- BM 35 Lumbago & Sciatica
Beyond the preview
Go deeper on BM-35.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BM-35.